Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action

Eur Heart J. 2018 Aug 7;39(30):2793-2799. doi: 10.1093/eurheartj/ehx027.

Antoni Bayes-Genis^{1

2

3}, Adriaan A Voors⁴, Faiez Zannad⁵, James L Januzzi⁶, A Mark Richards^{7

8}, Javier Díez^{3

9

10}

¹ Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
² Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
³ CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.
⁴ Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
⁵ INSERM, CIC1433, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
⁶ Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
⁷ Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.
⁸ Cardiovascular Research Institute, National University of Singapore, Singapore.
⁹ Program of Cardiovascular Diseases, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.
¹⁰ Department of Cardiology and Cardiac Surgery, University Clinic, University of Navarra, Pamplona, Spain.

No abstract available

Publication types